EP2139507A4 - Verfahren und zusammensetzungen zur förderung und erhaltung des knochenwachstums - Google Patents

Verfahren und zusammensetzungen zur förderung und erhaltung des knochenwachstums

Info

Publication number
EP2139507A4
EP2139507A4 EP07776368A EP07776368A EP2139507A4 EP 2139507 A4 EP2139507 A4 EP 2139507A4 EP 07776368 A EP07776368 A EP 07776368A EP 07776368 A EP07776368 A EP 07776368A EP 2139507 A4 EP2139507 A4 EP 2139507A4
Authority
EP
European Patent Office
Prior art keywords
stimulating
compositions
methods
bone growth
preserving bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07776368A
Other languages
English (en)
French (fr)
Other versions
EP2139507A1 (de
Inventor
Agnes Vignery
Nozer M Mehta
James P Gilligan
Kieran P Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Unigene Laboratories Inc
Original Assignee
Yale University
Unigene Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University, Unigene Laboratories Inc filed Critical Yale University
Publication of EP2139507A1 publication Critical patent/EP2139507A1/de
Publication of EP2139507A4 publication Critical patent/EP2139507A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
  • Surgical Instruments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP07776368A 2007-04-27 2007-04-27 Verfahren und zusammensetzungen zur förderung und erhaltung des knochenwachstums Withdrawn EP2139507A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/010267 WO2008133618A1 (en) 2007-04-27 2007-04-27 Methods and compositions for fostering and preserving bone growth

Publications (2)

Publication Number Publication Date
EP2139507A1 EP2139507A1 (de) 2010-01-06
EP2139507A4 true EP2139507A4 (de) 2012-06-06

Family

ID=39925939

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07776368A Withdrawn EP2139507A4 (de) 2007-04-27 2007-04-27 Verfahren und zusammensetzungen zur förderung und erhaltung des knochenwachstums

Country Status (6)

Country Link
EP (1) EP2139507A4 (de)
JP (1) JP2010526064A (de)
CN (1) CN101663043B (de)
AU (1) AU2007352435B2 (de)
CA (1) CA2685407A1 (de)
WO (1) WO2008133618A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3345607T1 (sl) 2006-12-29 2023-03-31 Ossifi-Mab Llc Postopki spreminjanja rasti kosti z dajanjem antagonista ali agonista SOST ali WISE
CN101966348B (zh) * 2010-09-21 2014-03-26 中国科学院深圳先进技术研究院 掺锶羟基磷灰石胶原复合材料及其应用和制备方法
TWI573558B (zh) * 2015-09-30 2017-03-11 愛派司生技股份有限公司 一種含具有複數螺紋區之骨螺釘的骨板組
CN117502351A (zh) * 2023-11-17 2024-02-06 西藏自治区农牧科学院水产科学研究所 一种拉萨裂腹鱼苗种批量化标记方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080933A1 (en) * 2001-04-03 2002-10-17 The Royal Alexandra Hospital For Children A drug for use in bone grafting
WO2004078223A1 (en) * 2003-03-05 2004-09-16 Bone Support Ab A new bone substitute composition
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
WO2006124708A1 (en) * 2005-05-19 2006-11-23 Unigene Laboratories, Inc. Bone implant device and methods of using same
WO2007038009A2 (en) * 2005-09-26 2007-04-05 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724897D0 (en) * 1987-10-23 1987-11-25 Downes S Material
ES2262642T3 (es) * 2000-04-05 2006-12-01 Kyphon Inc. Dispositivo para el tratamiento de huesos fracturados y/o enfermos.
JP2004511320A (ja) * 2000-10-16 2004-04-15 ユニバーシテイ・オブ・サウス・カロライナ 反応性リン酸カルシウムナノ粒子を含む生体適合性セメント並びに前記セメントの製造及び使用方法
CN1294885C (zh) * 2001-06-05 2007-01-17 江苏阳生生物工程有限公司 人体骨组织生物工程支架制品及其制备方法和用途
TWI267378B (en) * 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
AU2002327007B2 (en) * 2001-09-21 2005-10-20 Stryker Corporation Pore-forming agents for orthopedic cements
JP2005519067A (ja) * 2002-01-17 2005-06-30 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム トロンビンペプチド誘導体を用いた骨成長および軟骨形成の刺激
US9532994B2 (en) * 2003-08-29 2017-01-03 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7175858B2 (en) * 2004-07-26 2007-02-13 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
WO2006072622A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
JP2006263184A (ja) * 2005-03-24 2006-10-05 Gc Corp 骨セメント注入充填方法及び骨セメント注入充填用漏洩防止袋
CA2608016A1 (en) * 2005-05-11 2006-11-23 Unigene Laboratories, Inc. Improving bone formation and preservation by surgically inducing an increase in osteoblast activity coupled with the effect of administering pthrp or cgrp

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002080933A1 (en) * 2001-04-03 2002-10-17 The Royal Alexandra Hospital For Children A drug for use in bone grafting
WO2004078223A1 (en) * 2003-03-05 2004-09-16 Bone Support Ab A new bone substitute composition
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
WO2006124708A1 (en) * 2005-05-19 2006-11-23 Unigene Laboratories, Inc. Bone implant device and methods of using same
WO2007038009A2 (en) * 2005-09-26 2007-04-05 Depuy Spine, Inc. Tissue augmentation, stabilization and regeneration technique

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008133618A1 *
SKRIPITZ R ET AL: "Parathyroid hormone (1-34) increases attachment of PMMA cement to bone", JOURNAL OF ORTHOPAEDIC SCIENCE, SPRINGER VERLAG. TOKYO, JP, vol. 6, no. 6, 1 January 2001 (2001-01-01), pages 540 - 544, XP002533458, ISSN: 0949-2658, DOI: 10.1007/S007760100010 *
SKRIPITZ R ET AL: "Strong effect of PTH (1-34) on regenerating bone: A time sequence study in rats", ACTA ORTHOPAEDICA SCANDINAVICA, MUNKSGAARD, COPENHAGEN, DK, vol. 71, no. 6, 1 December 2000 (2000-12-01), pages 619 - 624, XP002319215, ISSN: 0001-6470, DOI: 10.1080/000164700317362271 *

Also Published As

Publication number Publication date
CN101663043B (zh) 2014-03-12
EP2139507A1 (de) 2010-01-06
JP2010526064A (ja) 2010-07-29
CA2685407A1 (en) 2008-11-06
AU2007352435B2 (en) 2012-01-19
CN101663043A (zh) 2010-03-03
WO2008133618A1 (en) 2008-11-06
AU2007352435A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
BRPI0807918A2 (pt) composições e método para preservação de tecido
EP2214597A4 (de) Wirbelsäulenimplantate und verfahren
EP2134299A4 (de) Perkutane wirbelsäulenimplantate und verfahren
ZA201001810B (en) Seed treatment compositions and methods
ZA201001811B (en) Seed treatment compositions and methods
EP2124780A4 (de) Wirbelfortsatzimplantate und relevante verfahren
BRPI0717732A2 (pt) Guia cirúrgica para implante dental e métodos para o mesmo
DK2473034T3 (da) Frøbehandlingssammensætninger og fremgangsmåde
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
FI20085839A0 (fi) Menetelmiä ja välineitä pehmytkudosteknologiaan
EP2120561A4 (de) Zusammensetzungen zur bearbeitung von biofolien und verfahren zu ihrer verwendung
EP2173265A4 (de) Fazettengelenkimplantat und relevante verfahren
EP2262474A4 (de) Verfahren und zusammensetzungen zur wundheilung
EP2413825A4 (de) Dornfortsatzimplantate und zugehörige verfahren
EP2117471A4 (de) Wirbelsäulenimplantat
BRPI0811158A2 (pt) Composições e métodos de preservação de alimento
ZA200906390B (en) Compositions and methods for promoting bone development
IL207132A0 (en) Composition and method for seed treatment use
ZA200900388B (en) Compositions and methods for the treatment of mucositis
EP2459187A4 (de) Zusammensetzungen und verfahren zur hemmung von haarwachstum
BRPI0919150A2 (pt) aplicadores de fluxo de ar e métodos de tratamento relacionados
BRPI0817964A2 (pt) Implante cirúrgico
DK2428181T3 (da) Ensartet alveolært benmejsel og knoglespreder til tandimplantat
PL2349231T3 (pl) Kompozycje i metody leczenia chorób kopyta
IL201803A0 (en) Interspinous implants and methods for implanting same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091028

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20120501BHEP

Ipc: A61K 38/29 20060101AFI20120501BHEP

Ipc: A61P 19/00 20060101ALI20120501BHEP

Ipc: A61K 38/17 20060101ALI20120501BHEP

Ipc: A61K 31/59 20060101ALI20120501BHEP

Ipc: A61K 38/23 20060101ALI20120501BHEP

Ipc: A61K 38/18 20060101ALI20120501BHEP

Ipc: A61K 38/27 20060101ALI20120501BHEP

Ipc: A61K 38/30 20060101ALI20120501BHEP

17Q First examination report despatched

Effective date: 20140213

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140826